Logan Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$283K Hold
3,621
0.01% 250
2025
Q1
$262K Hold
3,621
0.01% 269
2024
Q4
$268K Hold
3,621
0.01% 273
2024
Q3
$239K Hold
3,621
0.01% 279
2024
Q2
$334K Hold
3,621
0.01% 263
2024
Q1
$346K Hold
3,621
0.01% 265
2023
Q4
$276K Sell
3,621
-18
-0.5% -$1.37K 0.01% 274
2023
Q3
$252K Hold
3,639
0.01% 272
2023
Q2
$343K Hold
3,639
0.02% 259
2023
Q1
$301K Hold
3,639
0.01% 273
2022
Q4
$272K Hold
3,639
0.01% 276
2022
Q3
$301K Hold
3,639
0.02% 260
2022
Q2
$346K Hold
3,639
0.02% 260
2022
Q1
$428K Sell
3,639
-525
-13% -$61.7K 0.02% 255
2021
Q4
$539K Hold
4,164
0.02% 250
2021
Q3
$471K Hold
4,164
0.02% 258
2021
Q2
$431K Buy
4,164
+15
+0.4% +$1.55K 0.02% 255
2021
Q1
$347K Buy
4,149
+18
+0.4% +$1.51K 0.02% 257
2020
Q4
$377K Buy
4,131
+510
+14% +$46.5K 0.02% 280
2020
Q3
$289K Sell
3,621
-1,200
-25% -$95.8K 0.02% 339
2020
Q2
$333K Hold
4,821
0.02% 264
2020
Q1
$303K Sell
4,821
-231
-5% -$14.5K 0.02% 282
2019
Q4
$393K Buy
5,052
+21
+0.4% +$1.63K 0.02% 269
2019
Q3
$369K Hold
5,031
0.02% 268
2019
Q2
$310K Hold
5,031
0.02% 272
2019
Q1
$321K Hold
5,031
0.02% 270
2018
Q4
$257K Hold
5,031
0.02% 262
2018
Q3
$292K Buy
5,031
+210
+4% +$12.2K 0.02% 265
2018
Q2
$234K Buy
+4,821
New +$234K 0.02% 272
2013
Q3
Sell
-882,474
Closed -$15.2M 265
2013
Q2
$15.2M Buy
+882,474
New +$15.2M 1.22% 25